Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | PDE4A | P27815 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.33 |
| ▸ | TOP1 | P11387 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL616881 | 1.00 | LMNA (0.42) | LMNAL3MBTL1TDP1AKR1B1KDM4E | |
| SCHEMBL1001172 | 1.00 | LMNA (0.42) | LMNAL3MBTL1TDP1AKR1B1KDM4E | |
| SCHEMBL64935 | 1.00 | LMNA (0.42) | LMNAL3MBTL1TDP1AKR1B1KDM4E | |
| SCHEMBL3130561 | 0.94 | LMNA (0.46) | LMNAL3MBTL1TDP1AKR1B1KDM4E | |
| SCHEMBL33584 | 0.94 | LMNA (0.46) | LMNAL3MBTL1TDP1AKR1B1KDM4E | |
| SCHEMBL1369560 | 0.94 | LMNA (0.46) | LMNAL3MBTL1TDP1AKR1B1KDM4E | |
| SCHEMBL4126076 | 0.94 | LMNA (0.46) | LMNAL3MBTL1TDP1AKR1B1KDM4E | |
| SCHEMBL3128140 | 0.94 | LMNA (0.46) | LMNAL3MBTL1TDP1AKR1B1KDM4E | |
| SCHEMBL342904 | 0.94 | LMNA (0.46) | LMNAL3MBTL1TDP1AKR1B1KDM4E | |
| SCHEMBL2316246 | 0.94 | LMNA (0.46) | LMNAL3MBTL1TDP1AKR1B1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 718 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112469478-A | Microbiome composition for treating cancer | 赛里斯治疗公司 | 2021-03-09 | — | — | CN | claimed |
| CN-110267651-A | Method for enhancing immune checkpoint blockade therapy by modulating microbiome | 得克萨斯系统大学评议会 | 2019-09-20 | — | — | CN | claimed |
| CN-110114471-A | For diet intervention or the adjoint diagnostic method of fecal microorganism group's transplantation treatment irritable bowel syndrome | 遗传分析股份有限公司 | 2019-08-09 | — | — | CN | claimed |
| CN-109125141-A | A kind of make-up remover | 南通三观文化发展有限公司 | 2019-01-04 | — | — | CN | claimed |
| CN-109125143-A | A kind of mild make-up remover | 南通三观文化发展有限公司 | 2019-01-04 | — | — | CN | claimed |
| CN-103655409-A | Makeup remover | QINGDAO CHENXUTONG COMMERCE & TRADE CO LTD | 2014-03-26 | — | — | CN | claimed |
| CN-102223886-A | Erbb-3 (her3)-selective combination therapy | ENZON PHARMACEUTICALS INC | 2011-10-19 | — | — | CN | claimed |
| CN-101309599-A | High-potency sweetener compositions containing saponins and compositions sweetened therewith | COCA COLA CO (US) | 2008-11-19 | — | — | CN | claimed |
| EP-1959759-A2 | HIGH POTENCY SWEETENER COMPOSITION WITH SAPONIN AND COMPOSITIONS SWEETENED THEREWITH | The Coca-Cola Company (US) | 2008-08-27 | — | — | EP | claimed |
| EP-1861704-A2 | IDENTIFICATION OF BACTERIA AND SPORES | Correlogic Systems, Inc. (US) | 2007-12-05 | — | — | EP | claimed |
| WO-2007061872-A2 | HIGH POTENCY SWEETENER COMPOSITION WITH SAPONIN AND COMPOSITIONS SWEETENED THEREWITH | THE COCA-COLA COMPANY (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116822-A1 | HIGH-POTENCY SWEETENER COMPOSITION WITH SAPONIN AND COMPOSITIONS SWEETENED THEREWITH | THE COCA-COLA COMPANY (US) | 2007-05-24 | — | — | US | claimed |
| WO-2007053170-A2 | IDENTIFICATION OF BACTERIA AND SPORES | CORRELOGIC SYSTEMS, INC. (US) | 2007-05-10 | — | — | WO | claimed |
| EP-0151577-B1 | NEW GLUCIDIC DERIVATIVES OF 5-HYDROXYTRYPTOPHANE, OBTENTION AND APPLICATION AS DRUGS | OEUVRES HOSPITALIERES FRANCAISES DE L'ORDRE DE MALTE (FR) | 1989-03-08 | — | — | EP | claimed |
| EP-0151577-A1 | NEW GLUCIDIC DERIVATIVES OF 5-HYDROXYTRYPTOPHANE, OBTENTION AND APPLICATION AS DRUGS. | OEUVRES HOSPITALIERES FRANCAIS (FR) | 1985-08-21 | — | — | EP | claimed |
| WO-1984004310-A1 | NEW GLUCIDIC DERIVATIVES OF 5-HYDROXYTRYPTOPHANE, OBTENTION AND APPLICATION AS DRUGS | MALTE OEUVRES HOSPITAL FSE (FR) | 1984-11-08 | — | — | WO | claimed |
| US-4154744-A | Process for producing a furan derivative | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1979-05-15 | — | — | US | claimed |
| JP-4278095-A | — | — | None | — | — | JP | disclosed |
| US-3950545-A | Baked product containing protein and vitamins and process for preparing same | THE QUAKER OATS COMPANY (US) | 1976-04-13 | — | — | US | disclosed |
| US-3943012-A | Magnetic recording medium | FUJI PHOTO FILM CO., LTD. (JA) | 1976-03-09 | — | — | US | disclosed |